These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8665555)

  • 1. Effects of calcium antagonists on the dopamine system.
    Mena MA; Garcia de Yébenes MJ; Tabernero C; Casarejos MJ; Pardo B; Garcia de Yébenes J
    Clin Neuropharmacol; 1995 Oct; 18(5):410-26. PubMed ID: 8665555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical investigation on the effects of a new diphenylpiperazine calcium antagonist, KB-2796, on the central dopaminergic system of rats.
    Ikegami A; Ozaki A; Hara H; Sukamoto T; Yamashita A; Ito K
    Jpn J Pharmacol; 1992 Apr; 58(4):399-405. PubMed ID: 1405037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the calcium channel blockers on rotation induced by apomorphine and amphetamine in rats lesioned with 6-hydroxydopamine].
    Tabernero C; Pardo B; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(2):49-53. PubMed ID: 1907126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury.
    Lipton SA
    Ann Neurol; 1991 Jul; 30(1):110-4. PubMed ID: 1656845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of [3H]dopamine uptake by flunarizine.
    Devoto P; Pani L; Kuzmin A; De Montis G
    Eur J Pharmacol; 1991 Oct; 203(1):67-9. PubMed ID: 1797556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
    Ritchie DM; Sierchio JN; Bishop CM; Hedli CC; Levinson SL; Capetola RJ
    J Pharmacol Exp Ther; 1984 Jun; 229(3):690-5. PubMed ID: 6202868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
    Dobrev D; Milde AS; Andreas K; Ravens U
    Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists stimulate sperm motility in ejaculated human semen.
    Hong CY; Chiang BN; Ku J; Wei YH; Fong JC
    Br J Clin Pharmacol; 1985 Jan; 19(1):45-9. PubMed ID: 3919750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of Ca2+ antagonists on two types of Ca2+ channels in rat aorta smooth muscle cells in primary culture.
    Kuga T; Sadoshima J; Tomoike H; Kanaide H; Akaike N; Nakamura M
    Circ Res; 1990 Aug; 67(2):469-80. PubMed ID: 2165445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin effect on dopamine release and calcium transport in rat striatum: interactions with diphenylalkylamine calcium antagonists.
    Battaini F; Govoni S; Di Giovine S; Trabucchi M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):267-70. PubMed ID: 3713871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylalkylamine calcium antagonists interact with alpha-adrenoceptor binding sites in aortic membranes.
    Descombes JJ; Stoclet JC
    Eur J Pharmacol; 1985 Sep; 115(2-3):313-6. PubMed ID: 2998828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice.
    Grebb JA
    Life Sci; 1986 Jun; 38(26):2375-81. PubMed ID: 3724362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis, calcium, and calcium antagonists.
    Henry PD
    Circulation; 1985 Sep; 72(3):456-9. PubMed ID: 3893790
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Ca2+ channel antagonists in guinea-pig normal and skinned gall bladder.
    Cejalvo D; Calvo MA; Lloris JM; Cortijo J; Morcillo EJ
    Eur J Pharmacol; 1993 Mar; 234(1):23-8. PubMed ID: 8472758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats.
    Kato T; Otsu Y; Furune Y; Yamamoto T
    Neurochem Int; 1992 Jul; 21(1):99-107. PubMed ID: 1303146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of different Ca2+ entry blockers on dopamine-induced inhibition of in vitro prolactin secretion.
    Di Renzo G; Amoroso S; Maida P; Canzoniero L; Nappi C; Taglialatela M; Annunzia L
    Eur J Pharmacol; 1988 Feb; 146(2-3):201-6. PubMed ID: 3371396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of verapamil, diltiazem and ryosidine on the release of dopamine and acetylcholine in rabbit caudate nucleus slices.
    Starke K; Späth L; Wichmann T
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):124-30. PubMed ID: 6144047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pupillary and vascular effects of calcium antagonists in migraine.
    Fanciullacci M; Boccuni M; Pietrini U; Cangi F; Gatto G; Marabini S; Fusco BM
    Cephalalgia; 1985 May; 5 Suppl 2():181-3. PubMed ID: 4016932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.